Thursday November 26 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Goldshield Group plc

The first pharmaceutical product was acquired from Glaxo in 1992 and there have been subsequent product acquisitions from SmithKline Beecham, Medeva, Warner Lambert and American Home Products. Between 1991 and 1993, the Group raised equity finance of £1.0 million from individual investors, many of whom are doctors, pharmacists, or from within the pharmaceutical industry. The Group became profitable in the year ended 31 March 1993.


Contact Details:
NLA Tower 12-16 Addiscombe Road
Croydon
Surrey
CR0 0XT
United Kingdom
Tel:44 (0) 208 649 8500
Fax:44 (0) 208 686 0807
Email:info@goldshieldplc.com
WWW:

www.goldshieldplc.com/




Loading...

BioNews Results for Goldshield Group plc:

Pfizer in no rush to integrate local Wyeth distributor: Pfizer Israel country manager Ofra Feinmesser: The imp
TradingMarkets:  Oct 23 2009 12:42AM Matching: goldshield group plc
Pfizer in no rush to integrate local Wyeth distributor
Globes:  Oct 22 2009 6:56PM Matching: goldshield group plc

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 284 times since April 2007, the link to the organisation's website has been followed 65 times

Search for more companies in Croydon

Search for more companies in Surrey



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Goldshield Group plc

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.